Supriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. The company plans to achieve this goal by expanding its product basket with the addition of six to seven molecules, targeting areas such as anti-anxiety, anesthesia, and anti-diabetes.
